RAF proteins exert both specific and compensatory functions during tumour progression of NRAS-driven melanoma
出版年份 2017 全文链接
标题
RAF proteins exert both specific and compensatory functions during tumour progression of NRAS-driven melanoma
作者
关键词
-
出版物
Nature Communications
Volume 8, Issue -, Pages 15262
出版商
Springer Nature
发表日期
2017-05-12
DOI
10.1038/ncomms15262
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High-throughput Phenotyping of Lung Cancer Somatic Mutations
- (2016) Alice H. Berger et al. CANCER CELL
- Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma
- (2014) Marcin Imielinski et al. JOURNAL OF CLINICAL INVESTIGATION
- Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migration
- (2014) J. Mooz et al. Science Signaling
- RAF Inhibitors Activate the MAPK Pathway by Relieving Inhibitory Autophosphorylation
- (2013) Matthew Holderfield et al. CANCER CELL
- Tumor adaptation and resistance to RAF inhibitors
- (2013) Piro Lito et al. NATURE MEDICINE
- Histopathological atlas and proposed classification for melanocytic lesions inTyr::NRasQ61K; Cdkn2a−/−transgenic mice
- (2013) Cécile Campagne et al. Pigment Cell & Melanoma Research
- Activated Mutant NRasQ61K Drives Aberrant Melanocyte Signaling, Survival, and Invasiveness via a Rac1-Dependent Mechanism
- (2012) Ang Li et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
- (2012) Michael Krauthammer et al. NATURE GENETICS
- NRAS mutant melanoma: biological behavior and future strategies for therapeutic management
- (2012) I V Fedorenko et al. ONCOGENE
- Essential, non-redundant roles of B-Raf and Raf-1 in Ras-driven skin tumorigenesis
- (2012) F Kern et al. ONCOGENE
- ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers
- (2012) A P Rebocho et al. ONCOGENE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- B-Raf and C-Raf Are Required for Melanocyte Stem Cell Self-Maintenance
- (2012) Agathe Valluet et al. Cell Reports
- c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma
- (2011) Rafael B. Blasco et al. CANCER CELL
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- C-Raf Is Required for the Initiation of Lung Cancer by K-Ras G12D
- (2011) Florian A. Karreth et al. Cancer Discovery
- A Mouse Model of Melanoma Driven by Oncogenic KRAS
- (2010) C. Milagre et al. CANCER RESEARCH
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation
- (2010) P J Mishra et al. ONCOGENE
- Hyperactivation of MEK–ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells
- (2010) F M Kaplan et al. ONCOGENE
- Raf-1 Addiction in Ras-Induced Skin Carcinogenesis
- (2009) Karin Ehrenreiter et al. CANCER CELL
- Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma
- (2009) M. A. Davies et al. CLINICAL CANCER RESEARCH
- Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors
- (2009) Bijay S. Jaiswal et al. PLoS One
- Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
- (2008) C. Montagut et al. CANCER RESEARCH
- Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas
- (2008) Caroline Kannengiesser et al. Molecular Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started